Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Not yet recruiting
×
cabozantinib
×
Clear all
Filters
3
NCT07405164
2026-02-12
MK-6482-043
Merck Sharp & Dohme LLC
Phase 3
Not yet recruiting
450 enrolled